Determining Methods of Collaborative, Realistic, and Cost Effective Supply Timelines. Fatima Zaidi Clinical Trial Supply New England

Similar documents
INTRODUCTION TO MODERN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT SERVICES

Secure Interim Analysis Data Access. Management with ACES. Eric J. Silva, Cytel, Inc. Steven Ketchum, Ph.D., Sunesis Pharmaceuticals

PAREXEL ACCESS MANAGED ACCESS PROGRAMS

Simulation and Implementation of Drug Supply Strategies

Quality Assurance of Investigational Medicinal Products. Sue McKenzie PPQA (A)

PAREXEL PARTNER PROGRAM. Broaden your reach with a partner you can trust

DRUG ORDERING AND MAINTENANCE

End-to-End Management of Clinical Trials Data

CTS East Coast. Increasing Agility and Innovation in the Clinical Supply Chain for Cost Optimization. Connect with us to connect with Asia

IMP Management and Accountability

Pharmaceutical Development (Drug Substance & Drug Product) for Visceral Leishmaniasis candidate DNDI-6148

Table of Contents. Presented by

July 9. Course Catalog. Camstar Semiconductor Suite Release 6 CONFIDENTAL

SHOULD YOUR BARCODE LABELING SOLUTION BE FULLY INTEGRATED WITH YOUR BUSINESS SYSTEM?

The interface between Good Clinical Practice and Good Manufacturing Practice

Volunteering for Clinical Trials

Sean Hobday. Senior Vice President, International and Strategic Accounts

DELMIA Apriso for A&D DELMIA Apriso 2017 Conceptual Design

Recommendations for Strengthening the Investigator Site Community

Summary of Provisions in 21 st Century Cures Act (H.R. 6) as passed by full House of Representatives, July 10, 2015

Digital Evolution in Life Sciences Supply Chain and Strategic Procurement Processes

CLINICAL TRIAL ENROLLMENT FORECASTING A WEB-BASED PERFORMANCE MANAGEMENT APPLICATION

ISRCTN: EudraCT Number: Sponsor Protocol Number: UCL 08/0350. Pharmacy Manual

Vendor Selection: Identifying Effective Procedures & Strategies

LINEAR PROGRAMMING APPROACHES TO AGGREGATE PLANNING. Linear programming is suitable to determine the best aggregate plan.

Global Life Sciences BPO Market to be Worth USD 596 Billion by 2019: Transparency Market Research

KNOWLEDGE BRIEF. MIC Customs Solutions Is Recognized As the Technology Leader in the Global GTM Market by Quadrant Knowledge Solutions

Introduction to Clinical Research

global clinical trials. integrated solutions. reduced timelines.

CRO partner in Rx/CDx Co-Development

IND Drug Log Guidelines

PRIMARY CARE OPERATIONAL GUIDELINES

Dynamic Simulation and Supply Chain Management

New Cardinal Health (Post-Spin)

At the Heart of Connected Manufacturing

A High-Touch Approach to Improving Patient Access. Using field support to navigate reimbursement challenges

Oracle Buys ClearTrial Adds Leading Cloud-based Clinical Trial Operations and Analytics Applications to the Oracle Health Sciences Suite

Planning of Application

REQUEST FOR AUTHORISATION TO THE COMPETENT AUTHORITY: REQUEST FOR OPINION OF THE ETHICS COMMITTEE:

PAREXEL STRATEGIC PARTNERSHIPS. Optimizing relationships for shorter time to market

CTSA Trial Innovation Network Early Vision & Goals MONICA SHAH, MD DIRECTOR, TRIAL INNOVATION NETWORK

19 th Annual Clinical Trial Supply Europe Conference

Global Contract Research Organization (CRO) Market: Size, Trends & Forecasts ( ) November 2017

WHITE PAPER. Solutions to Global Pharmaceutical Supply Chain Challenges

Good Clinical Practice (GCP) & Clinical Trial Registries

19 th Annual Clinical Trial Supply Europe Conference

Role of IT. in a Supply Chain. Information Technology. in a Supply Chain. Use of Information

Q&A on ICH Q7 Good Manufacturing Practice Questions and Answers Document

Human Research Protection Program Good Clinical Practice Guidance for Investigators Regulatory File Essential Documents

Enabling faster insights to improve clinical trial efficiency and quality

Supplier Guide Book. Collaborate, perform, grow together

CHALLENGES OF GLOBAL CLINICAL TRIAL SUPPLY SOURCING SOME SPECIFICS FOR EMERGING MARKETS

Early Development Best Practices for Stability- Regulatory Perspective

Developing a European First-in-Human Study: Three Key Decisions

University Health Network UDI Capture Work Group Case Study

Corporate Brochure. Elevate Your Flexible Workforce Management and Services Procurement

GUIDANCE FOR INDUSTRY ON FIXED DOSE COMBINATIONS (FDCs)

The Process Diagnostic. How to optimize the technology transfer and the development

SWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL STUDY PROTOCOL CHAPTER 14 REVISED: OCTOBER 2015

The Aptuit Center for Drug Discovery & Development Verona, Italy

THE DOD/FDA SHELF LIFE EXTENSION PROGRAM TO EXTEND THE SHELF LIFE OF CRITICAL STOCKPILES OF MEDICAL MATERIEL FOR THE FEDERAL GOVERNMENT

2018 Confirmed Speakers

EFPIA layperson summary Principles that apply to Clinical Trial Transparency. Antonio Ferrari (Chiesi) & Solange Rohou (AZ)

Expanded Access. to Investigational Drugs & Biologics. for Treatment Use

The Integrated Support and Assurance Process (ISAP): detailed guidance on assuring novel and complex contracts

Document Reuse: Theory and Practice

Business Process Modeling for Supply Chain Transformation

Industry Perspective on Manufacturing in Early Development

Program Management Professional (PgMP)

MICROSOFT DYNAMICS GP. Product Capabilities and Business Ready Licensing Module Guide. Solutions

An Industry Perspective: Reducing the Complexity and Impact of Regulatory Changes in Latin America

GUIDELINES FOR THE USE OF CONTROLLED SUBSTANCES IN RESEARCH MICHIGAN STATE UNIVERSITY ENVIRONMENTAL HEALTH AND SAFETY

A White Paper by Exact Software ERP-II: Making ERP Deliver On Its Promise to the Enterprise. Business Unified

ORACLE RESPONSYS PROFESSIONAL SERVICES DESCRIPTIONS

SAP Leonardo Live. North America

How to rescue a clinical trial

Predictive Modelling of Recruitment and Drug Supply in Multicenter Clinical Trials

Innovation & Automation in Accounts Payable: Dramatic Shifts are Occurring, Is your Company Innovating Ahead of the Curve or Caught in Neutral?

Experience with Adaptive Dose-Ranging Studies in Early Clinical Development

CV Lars Jakob Rasmussen

TITLE: Research Pharmacy Standard Policy SOP #: INV-100 Page: 1 of 5 Effective Date: 8/31/17

Welcome to the ITS PMO! Start a new IT Project

How Logistics Enables the Healthcare Revolution. Richard Holmes Managing Director of Polar Speed Distribution Ltd, a UPS company

Course Outline TO TRAIN

TOTAL REWARDS AT NESTLÉ: MORE THAN JUST A POLICY

EFPIA-PHRMA PRINCIPLES FOR RESPONSIBLE CLINICAL TRIAL DATA SHARING REPORT ON THE 2016 MEMBER COMPANY SURVEY

Partner with the Global Leader in Drug Delivery Systems

Challenges of Analytical Method Transfer in the Pharmaceutical Industry

Brexit Guidance for Stakeholders Human and veterinary medicines

CHINA. Australia - China Life Science Summit. . Bio & Pharma Logistics

Keys to a successful WAREHOUSE MANAGEMENT SYSTEM (WMS)

VOLUME 4 Good manufacturing practices ANNEX 13 Manufacture of investigational medicinal products JULY 2003

Business Process Improvement (BPI) Shared Service

Expanded Access and the Individual Patient IND

Decoding Phase II Clinical Trial Terminations

Transcription:

Determining Methods of Collaborative, Realistic, and Cost Effective Fatima Zaidi Clinical Trial Supply New England - 2013

Drug Development and Clinical Supply Annual supply chain spending for drugs under clinical trials can be substantial e.g., accounting for 20% or more of company s R&D spending Fleischhacker, A., Y. Zhao (2007). Planning for Demand Failure: A Dynamic Lot Size Model for Clinical Trial Supply Chains 2

Clinical Supply Planning Management of complex program with multinational regulations, functions, activities, and interactions 3

Challenges in Clinical Supply Planning Complex distribution network Variable enrollment rate Patient Drop-outs Expiration dating Randomization Stratification Bulk availability constraints Weight based dosage Multiple dose levels 4

Clinical Supply Optimization Minimize Risk Insufficient Stock Minimize Cost Manfg./Pckg/ Distribution Late Resupply Waste/Rush orders Insufficient overage Workload 5

Project Management Approach for Clinical Supply Planning: Getting right inventory, to right place, at right time 6

Factors Ensuring Optimization in Clinical Supply Planning Team Structure Processes Tools Systems Communication Determining Methods of Collaborative, Realistic, and Cost Effective 7

Team Structure Industry trends in clinical supply team structure(s) 8

Industry trends in clinical supply team structure(s) For productive positioning of clinical supply teams Larger CTS groups tend to be more specialized by activities: - Demand planning - Clinical trial supply set-up (packaging design, label approval, etc.) - Inventory management - IVR set-up - Outsourcing - Logistics Increasing trend in CTS is to take a project management approach: - Dedicated CTS Project Manager (PM) assigned to clinical study - CTS PM handles all activities from start to finish (demand planning, packaging/labeling, vendor management) - CTS Program Manager assigned to coordinate/plan with multiple CTS PMs 9

Efficient Processes and Systems Lean processes and integrated systems Optimizing Processes Develop processes and tools appropriate for department and company size. Create process maps, assess gaps, and identify bottle necks. Remove bottle necks Integrating disparate systems used by vendors and sponsors Identify system/technology to integrate the systems: - Cost of system implementation - Time to build and validate the integrated system Single messaging standard across vendor and sponsor system (Extensible Markup Language XML) Determining Methods of Collaborative, Realistic and Cost Effective 10

Clinical Supply Systems Used across Biopharmaceutical Industry Software system Vendor Forecasting COMPASS Almac Optimizer/Tc Visualize Smart Supplies Bio Clinica CLINapps Labeling/Inventory Management Clinicopia Aptuit SAP CTSM add on POMS CMS CTSS, ERP system Freezerworks Lodestone, Inc. Honeywell Rockwell Automation Freezerworks IVR/IWR Management Almac, Cenduit, Perceptive/ClinPhone, PPD Prelude Vision United BioSource Corp. 11

Activity Planning Tool Standard lead times for clinical supply activities Activities Lead times* Demand planning (drug substance) 9-12 months Study supply agreement (b/w clinical and CTS) Demand planning bulk drug Forecasting distribution scenario analysis, initial supply, resupply quantities Vendor selection (RFP, Contracts, Timelines) 9 months 6-9 months 6 months 6 months - Packaging distribution vendor 6 months - IVR/IWR vendor (design build, UAT, launch 6 months Label approval Label translations Booklet label printing Packaging/Labeling, Import permits Distribution ( to depots) IVR UAT/ launch 6-7 months 6 months 6 months 3-4 months 3 months 1 month Distribution to sites 1-2 weeks * - Lead times are from First Patient in (FPI) 20 March 12 2013

Cost - Develop supply budget during design phase Start the race with finish line in sight Drug product cost - API - Manufacturing Study Parameters - Number of subjects, sites, countries - Global site distribution - Dosing, blinding, enrollment forecast Packaging & Labeling - blister/bottle - number of packaging campaigns, product expiry date - booklet label/number of languages - storage and distribution Other - IVR - expiry date management PLEASE INSERT Presentation title 13

Cost - Developing Initial Study Budget Example (hypothetical) Study Parameters/Specifications Cost Total Number of subjects; sites; and countries 500; 100; 8 Study duration, expiry date 3 years, 24 months Number of subject, visits, dosing Primary packaging (100 count bottles) with booklet label $ 10.00 Number of packaging campaigns 3 12, 20 mg 100 mg flexible dose Packaging cost (total number of bottles, 3 packaging campaigns) $80000.00 240,000.00 Storage cost (3 depots) per year $10,000.00 30,000.00 Distribution cost (per shipment, and return) $100.00, $125.00 10,000.00 Other, export permits, label translation $3000.00 10,000.00 Expiry date management, relabeling Variable 10,000.00 IVR/IWR (with returns module) $350,000 350000.00 Total 740,000.00 14

Communication, Collaboration, and Transparency Between Supply and Clinical Development Encourage involvement of supply personnel at the stage of protocol development to ensure feasibility of projected timelines. Early involvement of supply personnel during protocol development phase Robust activity and timeline planning Good communication, and frequent meetings with involved parties during study design and trial phase. (Clinical supply, Clinical development, Manufacturing, Analytical, Vendors) Cross functional coordination Determining Methods of Collaborative, Realistic, and Cost Effective 15

Other Programs/Tools To achieve clinical supply optimization Technical training programs in CTS E.g., 3 month apprenticeship with rotation(s) in manufacturing, analytical, packaging & labeling, distribution, shadowing program(s). Cross-functional trainings Within R&D organization to enhance alignment on processes and lead times Establishing KPIs/metrics to measure and improve performance: - On time delivery, Waste reduction People development Career ladder within CTS Ongoing training, Incentives PLEASE INSERT Presentation title 16

Questions/Comments 17